Key result
Heartfelt autonomous foot-measuring device linked to ~77% telemonitoring adherence versus traditional weighing scales.
Why the study?
Telemonitoring solutions have gained prominence for home monitoring, but patient and clinician enthusiasm and adherence rates have been inconsistent.
Does an autonomous foot-measuring home device improve monitoring adherence compared to traditional weighing scales in medium to high-risk chronic heart failure patients?
Observational (n=13)
Does an autonomous foot-measuring home device improve monitoring adherence compared to traditional weighing scales in medium to high-risk chronic heart failure patients?
Absolute Event Rate: 77% vs 8%
An autonomous foot-measuring device substantially improves daily home monitoring adherence compared to traditional weighing scales in patients with chronic heart failure.
May support autonomous HF monitoring to boost adherence; leaves open effects on outcomes and generalizability.
In recent years, telemonitoring solutions have gained prominence for monitoring patients at home. However, patient and clinician enthusiasm, as well as adherence rates, have been inconsistent. This article presents a primary care evaluation of an autonomous foot-measuring home device, designed to monitor physiological changes in medium to high-risk chronic heart failure patients at risk of decompensation. The Heartfelt device garnered positive reception among the 13 participating patients. Remarkably, in 77% of cases (10 patients), the device captured and transmitted patient data on more than half of the days each month, while only 8% (one patient) managed to provide equivalent daily measurements using weighing scales. These results indicate that the Heartfelt device holds promise as an effective telemonitoring solution for patients who face adherence challenges with traditional telemonitoring systems, and self-management checks more generally. By adopting this technology, healthcare providers may be better equipped to proactively manage chronic heart failure patients and improve overall patient outcomes.
No takes yet. Share an insight, caveat, or question.
Murugappan et al. (2023) conducted an observational in chronic heart failure (n=13). Heartfelt autonomous foot-measuring home device vs. weighing scales was evaluated on capturing and transmitting patient data on more than half of the days each month. The Heartfelt autonomous foot-measuring device achieved 77% adherence for data transmission on >50% of days per month, compared to 8% with traditional weighing scales.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: